Skip to main content

Table 1 Binding specificities of HS antibodies and characteristics of the recognised epitopes, extracted from [24]

From: Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Antibody

Sulfation preference

Disulfated preference

Binds monosulfated?

Oligosaccharide length required for significant binding

HS3B7V

Hep > 2S,NS > 6S,NS > HS > 6S,2S > 6S > 2S

2S, NS or 6S, NS

2S or 6S

>dp10

HS4E4V

HS > 6S,NS = 2S,NS > Hep > 6S > 6S,2S

2S, NS or 6S, NS

Only 6S

dp8

HS3A8V

Hep > 2S,NS = HS > 6S,NS > 6S > 6S,2S

2S, NS

Only 6S

dp6

AO4B08V

Hep > HS > 2S,NS > 6S > NS,6S > 6S,2S > 2S

2S, NS

2S or 6S

dp4

EV3C3V

Hep > 2S,NS > HS > 6S,NS > 6S,2S ≥ 6S

2S, NS

Only 6S

dp8

EW4G1V

Hep > 2S,NS > HS > 6S,NS ≥ 6S,2S = 6S > 2S

2S, NS

2S or 6S

dp8

  1. (dp) degree of polymerisation, i.e., a disaccharide is a dp2, tetrasaccharide a dp4, etc. (Hep) heparin, (HS) heparan sulfate, (NS) N-sulfate, (2S) 2-O-sulfate, (6S) 6-O-sulfate,